First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE

News published by Renovion Inc. concerning ARINA-1, administered via an optimized investigational eFlow^® Technology nebulizer.
 

Read the press release